The Feasibility of an Online Educational Lifestyle Program for People with Multiple Sclerosis: A Qualitative Analysis of Participant Semi-structured Interviews
Overview
Authors
Affiliations
Objective: To explore the feasibility of a randomised controlled trial of a multiple sclerosis online course (MSOC) via qualitative analysis of participant semi-structured interviews.
Methods: The MSOC was developed in two arms: intervention arm which contained evidence-based lifestyle modification recommendations, and standard-care arm which delivered information from MS websites reflecting standard advice. Participants were recruited via online advertisements, completed a baseline questionnaire, and randomised. Seven modules were delivered over six weeks. Course completers were invited to participate in semi-structured interviews. Within a qualitative paradigm, interviews were analysed using reflexive thematic analysis.
Results: Fourteen of the 17 course completers were interviewed: 86% (12/14) female; mean age 50 years; residing in Australia, New Zealand, and the USA, predominantly had relapsing-remitting MS, mean time from diagnosis 9.5 years, and patient-determined disease steps disability assessment distributed evenly across all three categories. Four themes were identified: 1) "Hearing our stories" (hope for the future, feeling represented, exploring the journey of others with MS, learning from diversity, and wanting to connect with others); 2) "Taking the plunge" (not wanting to be first, feelings of nervousness or reluctance and feeling confronted); 3) "The accessibility and safety of being online" (ease of access, going at your own pace, making it work and not letting others down); and 4) "unpacking the course" (ease of navigation, visuals, understandability, and length and timing).
Conclusion: Participants felt represented, found the course accessible and content was easy to understand. These experiences provide important insights and considerations for this digital health intervention.
Reece J, Jelinek G, Milanzi E, Simpson-Yap S, Neate S, Taylor K Neurol Sci. 2024; 46(2):835-844.
PMID: 39432178 PMC: 11772461. DOI: 10.1007/s10072-024-07811-2.
Russell R, He J, Black L, Begley A Health Expect. 2024; 27(5):e70012.
PMID: 39207907 PMC: 11361266. DOI: 10.1111/hex.70012.
Bevens W, Davenport R, Neate S, Yu M, Jelinek P, Jelinek G J Med Internet Res. 2024; 26:e53372.
PMID: 38335016 PMC: 10891496. DOI: 10.2196/53372.
Reece J, Yu M, Bevens W, Simpson-Yap S, Jelinek G, Jelinek P BMC Neurol. 2023; 23(1):249.
PMID: 37386385 PMC: 10308714. DOI: 10.1186/s12883-023-03298-0.
Neate S, Bevens W, Jelinek P, Gray K, Weiland T, Nag N Front Public Health. 2022; 10:1022185.
PMID: 36568793 PMC: 9768550. DOI: 10.3389/fpubh.2022.1022185.